Literature DB >> 18825513

A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa.

Charles Shagi1, Andrew Vallely, Stella Kasindi, Betty Chiduo, Nicola Desmond, Selephina Soteli, Natujwa Kavit, Lisa Vallely, Shelley Lees, Richard Hayes, David Ross.   

Abstract

Actively engaging communities in effective partnerships for the design and implementation of HIV prevention research is vital to the successful conduct of ethically robust, locally-appropriate clinical trials in developing countries. This is especially true in vulnerable at-risk sub-populations, where definitions of "community", "participation" and "representation" can be difficult to apply. This study was conducted to investigate the feasibility of a participatory model of community liaison among an occupational cohort of women at high-risk of HIV and sexually-transmitted infections in Mwanza City, northwest Tanzania in preparation for a Phase III vaginal microbicide trial. This approach was rooted in participatory action-orientated research and used tools adapted from participatory learning and action techniques. During the feasibility study, a mobile community-based sexual and reproductive health service for women working as informal food vendors or in traditional and modern bars, restaurants, hotels and guesthouses was established in 10 city wards. Participatory mapping was carried out by project fieldworkers and wards divided into 78 geographical clusters of facilities in consultation with community members and study participants. Representatives at cluster and ward level were elected in a process facilitated by the site Community Liaison Officer and a site-level Community Advisory Committee established. A logical framework was used to guide the implementation, monitoring and evaluation of the community liaison system (CLS) within the broader feasibility study. The CLS was essential to the successful conduct of the feasibility study and has now been consolidated and expanded as part of the on-going MDP301 Phase III microbicide trial in Mwanza. The participatory model presented in this paper is likely to be generalisable to other vulnerable, stigmatised, at-risk study populations in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825513     DOI: 10.1080/09540120701842803

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  23 in total

1.  Aligning community engagement with traditional authority structures in global health research: a case study from northern Ghana.

Authors:  Paulina O Tindana; Linda Rozmovits; Renaud F Boulanger; Sunita V S Bandewar; Raymond A Aborigo; Abraham V O Hodgson; Pamela Kolopack; James V Lavery
Journal:  Am J Public Health       Date:  2011-08-18       Impact factor: 9.308

2.  Engaging community to support HIV prevention research.

Authors:  Seema Sahay; Sanjay Mehendale
Journal:  East J Med       Date:  2011

3.  Structural and Interpersonal Benefits and Risks of Participation in HIV Research: Perspectives of Female Sex Workers in Guatemala.

Authors:  Shira M Goldenberg; Monica Rivera Mindt; Teresita Rocha Jimenez; Kimberly C Brouwer; Sonia Morales Miranda; Celia B Fisher
Journal:  Ethics Behav       Date:  2014-08-14

4.  How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Shelley Lees; Charles Shagi; Stella Kasindi; Selephina Soteli; Natujwa Kavit; Lisa Vallely; Sheena McCormack; Robert Pool; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2010-06-13       Impact factor: 2.652

5.  Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.

Authors:  Liza Dawson; Sheryl Zwerski
Journal:  Bioethics       Date:  2014-09-17       Impact factor: 1.898

6.  Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?

Authors:  Kristen Underhill
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

7.  What can qualitative research do for randomised controlled trials? A systematic mapping review.

Authors:  A O'Cathain; K J Thomas; S J Drabble; A Rudolph; J Hewison
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

8.  Working with Concepts: The Role of Community in International Collaborative Biomedical Research.

Authors:  V M Marsh; D K Kamuya; M J Parker; C S Molyneux
Journal:  Public Health Ethics       Date:  2011-03-02       Impact factor: 1.940

9.  Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Charles Shagi; Shelley Lees; Katherine Shapiro; Joseph Masanja; Lawi Nikolau; Johari Kazimoto; Selephina Soteli; Claire Moffat; John Changalucha; Sheena McCormack; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2009-10-09       Impact factor: 2.652

10.  Being useful: achieving indigenous youth involvement in a community-based participatory research project in Alaska.

Authors:  Tara Ford; Stacy Rasmus; James Allen
Journal:  Int J Circumpolar Health       Date:  2012-05-08       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.